Phase II CT-2103/Carboplatin in Ovarian Cancer
NCT00069901
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
82
Enrollment
INDUSTRY
Sponsor class
Conditions
Ovarian Neoplasm
Interventions
DRUG:
CT-2103 (poly(L)glutamate-paclitaxel)
DRUG:
carboplatin
Sponsor
CTI BioPharma